Global Albumin (as Excipient) Market Overview
Rising adoption of recombinant albumin-based drug delivery systems by pharmaceutical and biotechnology companies is one of the key factors driving the albumin (as excipient) market. For instance, in 2014, Novozymes Biopharma DK A/S announced that its albumin-based VELTIS technology is used by GlaxoSmithKline plc in the manufacturing of type II diabetes drug (Tanzeum and Eperzan) in Europe.
Various other factors such as increasing prevalence of chronic conditions, technological advancements, emerging markets in APAC and RoW, rising awareness about albumin as excipient, and increase in usage of albumin for non-therapeutic applications are also expected to propel the growth of the market.
However, the adverse reactions associated with albumin, rising shift toward serum-free solutions, and unfavorable reimbursement policies can hamper the market growth over the forecast period. The global albumin (as excipient) market is expected to grow at an approximate CAGR of 6.1% during forecast period, 2018–2023.
Avail a FREE Sample at https://www.marketresearchfuture.com/sample_request/7442
The choice of excipient is an important factor in the formulation of pharmaceuticals. Albumin as excipient in formulation has been reported to improve lyophilized cake formation, dissolving properties of API from lyophilized powder, and solubility.
Top Key Players
Some of the key players in the global albumin (as excipient) market are Albumedix A/S, Albumin Therapeutics, LLC, Baxalta Incorporated, Baxter International Inc., Biotest AG, CSL Behring LLC, Celgene, China Biologic Products, Inc., Grifols International, S.A, HiMedia Laboratories Pvt. Ltd., InVitria, Medxbio Pte Ltd., Mitsubishi Tanabe Pharma Corporation, Octapharma AG, RayBiotech, Inc., SeraCare Life Sciences, Sigma-Aldrich Co. (Merck KGaA), and others.
Albumin (as Excipient) Market Segmentation
The global albumin (as excipient) market is segmented based on type, application, end user, and region.
Intended Audience
- Government and Private Laboratories
- Research and Development (R&D) companies
- Biotechnology Laboratories
- Market Research and Consulting Service Providers
Market Segmentation and Key Market Players
Global Albumin (as Excipient) Market, by Type
- Human Serum Albumin
- Bovine Serum Albumin
- Recombinant Albumin
Global Albumin (as Excipient) Market, by Application
- Drug Formulation
- Drug Delivery
- Vaccines
- Medical Device Coating
- Culture Media & Stabilizers
- Diagnostics
- In Vitro Fertilization
- Others
Global Albumin (as Excipient) Market, by End User
- Pharmaceutical & Biotechnology Industry
- Academic and Research Institutes
- Others
Various other factors such as increasing prevalence of chronic conditions, technological advancements, emerging markets in APAC and RoW, rising awareness about albumin as excipient, and increase in usage of albumin for non-therapeutic applications are also expected to propel the growth of the market.
Browse Complete Premium Research Report Enabled with Detailed TOC at https://www.marketresearchfuture.com/reports/albumin-market-7442
Regional Analysis
Geographically Considering the current scope of the study, the above-mentioned segments are covered into the four global regions, namely the Americas, Europe, Asia-Pacific and the Middle East & African region.
The albumin (as excipient) market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European albumin (as excipient) market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The albumin (as excipient) market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The albumin (as excipient) market in the Middle East & Africa has been segmented into the Middle East and Africa.
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
5.3 Investment Opportunities
5.4 Pricing Analysis
Ask for an Amazing Discount at: https://www.marketresearchfuture.com/check-discount/7442
Chapter 8. Global Albumin (As Excipient) Market, By Region
8.1 Introduction
8.2 Americas
8.2.1 North America
8.2.1.1 U.S.
8.2.1.2 Canada
8.2.2 South America
8.3 Europe
8.3.1 Western Europe
8.3.1.1 Germany
8.3.1.2 France
8.3.1.3 Italy
8.3.1.4 Spain
8.3.1.5 UK
8.3.1.6 Rest Of Western Europe
8.3.2 Eastern Europe
8.4 Asia-Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest Of Asia-Pacific
8.5 Middle East & Africa
8.5.1 Middle East
8.5.2 Africa
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
+1 646 845 9312
Email: sales@marketresearchfuture.com
Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/albumin-market-7442